The $6 Billion Shot at Making New Antibiotics—Before the Old Ones Fail

Antimicrobials cost as much to develop as other drugs, but don’t earn the same returns. Congress could give drugmakers a boost, but time is running out.Thanks for listening to WIRED. Check back in tomorrow to hear more stories from WIRED.com.

Learn more about your ad choices. Visit podcastchoices.com/adchoices